Serum Proteomic Signatures of Rheumatoid Arthritis Risk and Response: Analysis of a Rheumatoid Arthritis Interception Trial.

Arthritis Rheumatol · 2026 · PMC13313106 · PMID 41657110

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

There was a nonsignificant trend toward greater reduction in CTLA4 levels between months 12 and 15 for those who progressed to RA (Figure 5C ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.